2019 annual financial data
Compass Therapeutics 2019 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -34,052,000 USD and net income was -34,744,000 USD.
Operating cash flow was -31,741,000 USD.
Get free Compass Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -34,052,000 USD
- Net income
- -34,744,000 USD
- Operating cash flow
- -31,741,000 USD